Viridien posts transcript of FY 2025 results presentation

Virios Therapeutics, Inc.

Virios Therapeutics, Inc.

VIRI

0.00
  • Viridien released the transcript of its FY 2025 results call attended by Chair and CEO Sophie Zurquiyah, CFO Jérôme Serve, and VP IR Alexandre Leroy.
  • Revenue reached USD 1.17 billion; segment adjusted EBITDA USD 551 million; net cash flow USD 107 million; gross debt cut USD 230 million to about USD 850 million.
  • 2026 net cash flow target reiterated at USD 100 million; management flagged softer first-half activity, with a second-half recovery expected.
  • Library CAPEX seen in the USD 165 million to USD 250 million range; US HPC expansion CAPEX set at USD 30 million to USD 35 million in 2026.
  • PEMEX exposure fell below USD 50 million; CFO said the full balance is overdue, with collections expected this year and assumed in guidance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viridien SA published the original content used to generate this news brief on May 26, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.